Abstract:Cytochrome P450 3A4 (CYP3A4), a key enzyme, is pivotal in metabolizing approximately half of the drugs used clinically. The genetic polymorphism of the CYP3A4 gene significantly influences individual variations in drug metabolism, potentially leading to severe adverse drug reactions (ADRs). In this study, we conducted a genetic analysis on CYP3A4 gene in 1163 Chinese Han individuals to identify the genetic variations that might affect their drug metabolism capabilities. For this purpose, a multiplex polymerase chain reaction (PCR) amplicon sequencing technique was developed, enabling us to perform the genotyping of CYP3A4 gene efficiently and economically on a large scale. As a result, a total of 14 CYP3A4 allelic variants were identified, comprising six previously reported alleles and eight new nonsynonymous variants that were nominated as new allelic variants *39–*46 by the PharmVar Association. Further, functional assessments of these novel CYP3A4 variants were undertaken by coexpressing them with cytochromes P450 oxidoreductase (CYPOR) in Saccharomyces cerevisiae microsomes. Immunoblot analysis indicated that with the exception of CYP3A4.40 and CYP3A4.45, the protein expression levels of most new variants were similar to that of the wild-type CYP3A4.1 in yeast cells. To evaluate their catalytic activities, midazolam was used as a probe drug. The results showed that variant CYP3A4.45 had almost no catalytic activity, whereas the other variants exhibited significantly reduced drug metabolism abilities. This suggests that the majority of the CYP3A4 variants identified in the Chinese population possess markedly altered capacities for drug metabolism. SIGNIFICANCE STATEMENT In this study, we established a multiplex polymerase chain reaction (PCR) amplicon sequencing method and detected the maximum number of new CYP3A4 variants in a single ethnic population. Additionally, we performed the functional characterizations of these eight novel CYP3A4 allele variants in vitro. This study not only contributes to the understanding of CYP3A4 genetic polymorphism in the Chinese Han population but also holds substantial reference value for their potential clinical applications in personalized medicine.

The repertoire of G-protein-coupled receptor variations in the Japanese population 54KJPN

Human genetic variation database, a reference database of genetic variations in the Japanese population

Identification and Functional Assessment of EightCYP3A4Allelic Variants39–46Detected in the Chinese Han Population

Genome-wide association meta-analysis identifies novel GP2 gene risk variants for pancreatic cancer in the Japanese population

Pharmacogenomics of GPCR Drug Targets

Deafness Gene Variations in a 1120 Nonsyndromic Hearing Loss Cohort

Population-specific putative causal variants shape quantitative traits

Genetic Polymorphisms And In Silico Mutagenesis Analyses Of Cyp2c9, Cyp2d6, And Cypor Genes In The Pakistani Population

Population-based Screening for Hereditary Colorectal Cancer Variants in Japan

JG2: an updated version of the Japanese population-specific reference genome

Characterizing the Genetic Polymorphisms in 370 Challenging Medically Relevant Genes Using Long-Read Sequencing Data from 41 Human Individuals among 19 Global Populations

The variation landscape of in a multi-ethnic Asian population

Exploring human rare disease variants from a multidimensional perspective illuminates receptor – G protein coupling diversity

Strong association between the 12q24 locus and sweet taste preference in the Japanese population revealed by genome-wide meta-analysis

Association study of 71 European Crohn's disease susceptibility loci in a Japanese population

TogoVar: A comprehensive Japanese genetic variation database

A deep catalogue of protein-coding variation in 983,578 individuals

G protein-coupled receptor (GPCR) pharmacogenomics

The Fine-Scale Genetic Structure And Evolution Of The Japanese Population

Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases

Unveiling novel genetic variants in 370 challenging medically relevant genes using the long read sequencing data of 41 samples from 19 global populations